Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.12 | -$0.07 | -$0.10 |
Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Vaxart, Inc. last posted its earnings results on Thursday, March 20th, 2025. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.05. The company had revenue of 15.19 M for the quarter and had revenue of 28.70 M for the year. Vaxart, Inc. has generated $0 earnings per share over the last year ($-0.0331 diluted earnings per share) and currently has a price-to-earnings ratio of -1.29. Vaxart, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/20/2025 | Q4 2024 | -$0.10 | -$0.01 | 0.09 | $20.77 M | $15.19 M |
11/13/2024 | Q3 2024 | -$0.10 | -$0.01 | 0.09 | $1.93 M | $4.93 M |
08/08/2024 | Q2 2024 | -$0.03 | -$0.01 | 0.02 | $100.00 K | $6.40 M |
05/13/2024 | Q1 2024 | -$0.16 | -$0.01 | 0.15 | $800.00 K | $2.18 M |
03/14/2024 | Q4 2023 | -$0.15 | -$0.01 | 0.14 | $833.33 K | $3.25 M |
11/02/2023 | Q3 2023 | -$0.18 | -$0.01 | 0.17 | $100.00 K | $446.00 K |
08/03/2023 | Q2 2023 | -$0.19 | -$0.02 | 0.17 | $83.33 K | $1.36 M |
05/04/2023 | Q1 2023 | -$0.19 | -$0.19 | 0 | $800.00 K | $278.00 K |
03/15/2023 | Q4 2022 | -$0.22 | -$0.02 | 0.2 | $675.00 K | $22.00 K |
11/08/2022 | Q3 2022 | N/A | -$0.02 | N/A | $50.00 K | $0 |
08/08/2022 | Q2 2022 | -$0.21 | -$0.02 | 0.19 | $96.75 K | $0 |
05/09/2022 | Q1 2022 | -$0.17 | -$0.02 | 0.15 | $125.00 K | $85.00 K |
02/24/2022 | Q4 2021 | -$0.17 | -$0.02 | 0.15 | $182.75 K | $74.00 K |
11/04/2021 | Q3 2021 | -$0.15 | -$0.01 | 0.14 | $118.40 K | $200.00 K |
08/05/2021 | Q2 2021 | -$0.14 | -$0.01 | 0.13 | $549.25 K | $112.00 K |
05/06/2021 | Q1 2021 | N/A | -$0.01 | N/A | $617.00 K | $506.00 K |
02/25/2021 | Q4 2020 | -$0.08 | -$0.01 | 0.07 | $4.35 M | $356.00 K |
11/12/2020 | Q3 2020 | -$0.09 | -$0.01 | 0.08 | $1.07 M | $265.00 K |
08/06/2020 | Q2 2020 | -$0.07 | -$0.01 | 0.06 | $1.27 M | $523.00 K |
05/12/2020 | Q1 2020 | -$0.01 | -$0.00 | 0.01 | $2.80 M | $2.90 M |
Vaxart, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based offlast year's report dates.
In the previous quarter, Vaxart, Inc. (:VXRT) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.05.
The conference call for Vaxart, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Vaxart, Inc.'s latest earnings report can be read online.
Vaxart, Inc. (:VXRT) has a recorded annual revenue of $28.70 M.
Vaxart, Inc. (:VXRT) has a recorded net income of $-66,948,000.Vaxart, Inc. has generated $-0.0331 earnings per share over the last four quarters.
Vaxart, Inc. (:VXRT) has a price-to-earnings ratio of -1.29 and price/earnings-to-growth ratio is -0.1.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED